Published in Am J Med on May 01, 1999
Primary prevention of colorectal cancer. Gastroenterology (2010) 3.20
Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society. Menopause (2008) 1.74
Cumulative risk of colon cancer up to age 70 years by risk factor status using data from the Nurses' Health Study. Am J Epidemiol (2009) 1.62
Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial. Cancer Epidemiol Biomarkers Prev (2008) 1.42
Meta-analyses of colorectal cancer risk factors. Cancer Causes Control (2013) 1.42
Making decisions about hormone replacement therapy. BMJ (2003) 1.38
Adipokines linking obesity with colorectal cancer risk in postmenopausal women. Cancer Res (2012) 1.35
Colorectal cancer in relation to postmenopausal estrogen and estrogen plus progestin in the Women's Health Initiative clinical trial and observational study. Cancer Epidemiol Biomarkers Prev (2009) 1.29
Postmenopausal levels of endogenous sex hormones and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2009) 1.24
Use of electronic medical records in oncology outcomes research. Clinicoecon Outcomes Res (2010) 1.21
Reproductive history and risk of colorectal cancer in postmenopausal women. J Natl Cancer Inst (2011) 1.16
Differences in epidemiologic risk factors for colorectal adenomas and serrated polyps by lesion severity and anatomical site. Am J Epidemiol (2013) 1.14
CDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival. Int J Cancer (2010) 1.11
Association between sex hormones and colorectal cancer risk in men and women. Clin Gastroenterol Hepatol (2012) 1.09
Gender, anthropometric factors and risk of colorectal cancer with particular reference to tumour location and TNM stage: a cohort study. Biol Sex Differ (2012) 1.09
Dietary phytoestrogen intake is associated with reduced colorectal cancer risk. J Nutr (2006) 1.08
Menopausal hormone therapy and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2009) 1.07
Primary and secondary prevention of colorectal cancer. Clin Med Insights Gastroenterol (2014) 1.07
Sex differences in colorectal cancer survival: population-based analysis of 164,996 colorectal cancer patients in Germany. PLoS One (2013) 1.05
Endogenous estrogen exposure in relation to distribution of histological type and estrogen receptors in gastric adenocarcinoma. Gastric Cancer (2008) 1.04
Systematic review of methods used in meta-analyses where a primary outcome is an adverse or unintended event. BMC Med Res Methodol (2012) 1.01
Body mass index and colon cancer risk in Chinese people: menopause as an effect modifier. Eur J Cancer (2006) 1.01
Estrogen plus progestin and colorectal cancer incidence and mortality. J Clin Oncol (2012) 1.00
Risk of second primary colorectal cancer among colorectal cancer cases: a population-based analysis. J Carcinog (2011) 1.00
Cardiovascular medication use and risk for colorectal cancer. Cancer Epidemiol Biomarkers Prev (2008) 0.99
Plasma choline metabolites and colorectal cancer risk in the Women's Health Initiative Observational Study. Cancer Res (2014) 0.98
The treatment of climacteric symptoms. Dtsch Arztebl Int (2012) 0.98
Sex hormones and colorectal cancer: what have we learned so far? J Natl Cancer Inst (2010) 0.96
Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma. Br J Cancer (2005) 0.96
The effects of transdermal and oral oestrogen replacement therapy on colorectal cancer risk in postmenopausal women. Br J Cancer (2004) 0.95
Postmenopausal hormone therapy and colorectal cancer risk by molecularly defined subtypes among older women. Gut (2011) 0.94
Bone mineral density and the subsequent risk of cancer in the NHANES I follow-up cohort. BMC Cancer (2002) 0.94
Sunlight, hormone replacement status and colorectal cancer risk in postmenopausal women. Int J Cancer (2010) 0.93
Postmenopausal hormone therapy: risks and benefits. Nat Rev Endocrinol (2013) 0.93
Menopausal hormone therapy use and risk of invasive colon cancer: the California Teachers Study. Am J Epidemiol (2010) 0.92
Cancer of the colon and rectum: potential effects of sex-age interactions on incidence and outcome. Med Sci Monit (2013) 0.92
Estrogen receptor-β protects against colitis-associated neoplasia in mice. Int J Cancer (2012) 0.92
Hormone therapy, DNA methylation and colon cancer. Carcinogenesis (2010) 0.91
Expression of estrogen receptor beta in human colorectal cancer. World J Gastroenterol (2004) 0.88
Energy balance modulates colon tumor growth: Interactive roles of insulin and estrogen. Mol Carcinog (2010) 0.87
Common single-nucleotide polymorphisms in the estrogen receptor β promoter are associated with colorectal cancer survival in postmenopausal women. Cancer Res (2012) 0.86
Association of estrogen receptor beta variants and serum levels of estradiol with risk of colorectal cancer: a case control study. BMC Cancer (2012) 0.86
Primary prevention of colorectal cancer: myth or reality? World J Gastroenterol (2014) 0.86
Hormone replacement therapy, body mass, and the risk of colorectal cancer among postmenopausal women from Germany. Br J Cancer (2007) 0.86
Estrogen and progesterone-related gene variants and colorectal cancer risk in women. BMC Med Genet (2011) 0.85
Serum level of soluble 70-kD heat shock protein is associated with high mortality in patients with colorectal cancer without distant metastasis. Cell Stress Chaperones (2009) 0.85
Estrogen receptor β potentiates the antiproliferative effect of raloxifene and affects the cell migration and invasion in HCT-116 colon cancer cells. J Cancer Res Clin Oncol (2012) 0.85
Postmenopausal hormone therapy is associated with a reduced risk of colorectal cancer lacking CDKN1A expression. Cancer Res (2012) 0.84
A large prospective study of risk factors for adenocarcinomas and malignant carcinoid tumors of the small intestine. Cancer Causes Control (2013) 0.84
Reproductive factors and risk of esophageal squamous cell carcinoma in northern Iran: a case-control study in a high-risk area and literature review. Eur J Cancer Prev (2013) 0.83
Higher bone mineral density is associated with a decreased risk of colorectal adenomas. Int J Cancer (2010) 0.83
Hormone replacement therapy, oral contraceptive use, and distal large bowel cancer: a population-based case-control study. Am J Gastroenterol (2010) 0.83
Colon cancer risk and different HRT formulations: a case-control study. BMC Cancer (2007) 0.82
Colorectal cancer risk in relation to antidepressant medication use. Int J Cancer (2011) 0.82
Gender-related survival differences associated with polymorphic variants of estrogen receptor-β (ERβ) in patients with metastatic colon cancer. Pharmacogenomics J (2010) 0.82
A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort study. BMC Cancer (2012) 0.82
Menopausal hormone therapy and cancer: changing clinical observations of target site specificity. Steroids (2014) 0.82
Oral contraceptive use and colorectal cancer in the Nurses' Health Study I and II. Cancer Epidemiol Biomarkers Prev (2015) 0.82
Hormone therapy in relation to survival from large bowel cancer. Cancer Causes Control (2008) 0.82
No effect on adenoma formation in Min mice after moderate amount of flaxseed. Eur J Nutr (2004) 0.81
17 β-estradiol suppresses Helicobacter pylori-induced gastric pathology in male hypergastrinemic INS-GAS mice. Carcinogenesis (2011) 0.81
A prospective study of oral contraceptive use and colorectal adenomas. Cancer Causes Control (2016) 0.81
Dietary isoflavone and the risk of colorectal adenoma: a case-control study in Japan. Br J Cancer (2009) 0.80
Strategies for colon cancer prevention. EPMA J (2010) 0.80
HT update: spotlight on estradiol/norethindrone acetate combination therapy. Clin Interv Aging (2008) 0.79
Vitamin D and estrogen receptor gene polymorphisms and the risk of colorectal cancer in Bulgaria. Int J Colorectal Dis (2006) 0.79
Proportion of colon cancer attributable to lifestyle in a cohort of US women. Cancer Causes Control (2015) 0.78
Reproductive and hormonal factors and mortality among women with colorectal cancer in the NIH-AARP Diet and Health Study. Br J Cancer (2015) 0.77
Menopausal hormone therapy and risks of colorectal adenomas and cancers in the French E3N prospective cohort: true associations or bias? Eur J Epidemiol (2012) 0.77
CYP19A1 single nucleotide polymorphism associations with CYP19A1, NFκB1, and IL6 gene expression in human normal colon and normal liver samples. Pharmgenomics Pers Med (2014) 0.77
Estrogen receptor beta reduces colon cancer metastasis through a novel miR-205 - PROX1 mechanism. Oncotarget (2016) 0.77
The interaction of age and hormone replacement therapy on colon adenoma risk. Cancer Detect Prev (2007) 0.77
Estrogen inhibits colon polyp formation by reducing angiogenesis in a carcinogen-induced rat model. Int J Endocrinol (2013) 0.75
The association between a functional CYP1A1 polymorphism and colorectal neoplasia risk in post menopausal women. Dig Dis Sci (2010) 0.75
Menstrual and Reproductive Factors and Risk of Gastric and Colorectal Cancer in Spain. PLoS One (2016) 0.75
Reproductive history and risk of colorectal adenocarcinoma in parous women: a Nordic population-based case-control study. Br J Cancer (2016) 0.75
Colors of vegetables and fruits and the risks of colorectal cancer. World J Gastroenterol (2017) 0.75
Reproductive and menstrual factors and colorectal cancer incidence in the Women's Health Initiative Observational Study. Br J Cancer (2016) 0.75
Patient gender as a factor associated with lymph node metastasis in T1 colorectal cancer: A systematic review and meta-analysis. Mol Clin Oncol (2017) 0.75
CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk. Br J Cancer (2016) 0.75
No association between germline variation in catechol-O-methyltransferase and colorectal cancer survival in postmenopausal women. Menopause (2014) 0.75
Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients. World J Gastroenterol (2017) 0.75
The importance of gender in patients with peritoneal metastases of appendiceal origin treated by cytoreduction and intraperitoneal chemotherapy: an analysis of 257 consecutive patients from an Australian centre. J Cancer Res Clin Oncol (2014) 0.75
[Aspects of gender in colorectal tumors]. Wien Med Wochenschr (2006) 0.75
Protective Effects of Female Reproductive Factors on Lauren Intestinal-Type Gastric Adenocarcinoma. Yonsei Med J (2018) 0.75
The influence of hormone therapies on colon and rectal cancer. Eur J Epidemiol (2016) 0.75
Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol (1985) 26.13
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med (1997) 18.85
Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol (1992) 17.17
Total energy intake: implications for epidemiologic analyses. Am J Epidemiol (1986) 16.34
Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med (2001) 14.48
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med (1995) 11.08
Body weight and mortality among women. N Engl J Med (1995) 11.04
Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol (1989) 10.98
Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol (1986) 10.84
Validity of self-reported waist and hip circumferences in men and women. Epidemiology (1990) 10.57
Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol (1994) 9.90
Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc (1993) 9.90
Aspirin and the risk of colorectal cancer in women. N Engl J Med (1995) 9.59
Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol (1999) 9.34
Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J (1985) 9.28
Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med (1990) 8.98
Prospective study of alcohol consumption and risk of coronary disease in men. Lancet (1991) 8.64
A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA (1995) 8.60
Test of the National Death Index. Am J Epidemiol (1984) 8.46
Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med (1997) 8.43
Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation (2000) 8.17
Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet (1991) 7.87
Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care (1994) 7.11
Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA (1998) 7.09
Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire. Am J Clin Nutr (1999) 7.02
Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA (1997) 6.92
Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science (1998) 6.50
Test of the National Death Index and Equifax Nationwide Death Search. Am J Epidemiol (1994) 6.47
The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med (2001) 6.37
Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med (1993) 6.37
Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men. Arch Intern Med (2001) 6.23
Abdominal adiposity and coronary heart disease in women. JAMA (1998) 6.21
Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med (1999) 6.17
A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med (1990) 6.06
A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med (1993) 5.87
The assessment of alcohol consumption by a simple self-administered questionnaire. Am J Epidemiol (1991) 5.60
Methods used to quit smoking in the United States. Do cessation programs help? JAMA (1990) 5.57
Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med (1995) 5.42
Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med (1994) 5.42
The use of a self-administered questionnaire to assess diet four years in the past. Am J Epidemiol (1988) 5.32
Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study. JAMA (1993) 5.31
Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst (1999) 5.27
A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med (2000) 5.17
Prospective study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr (2000) 5.17
A prospective cohort study of vasectomy and prostate cancer in US men. JAMA (1993) 5.09
Intake of trans fatty acids and risk of coronary heart disease among women. Lancet (1993) 5.00
Postmenopausal hormone therapy and mortality. N Engl J Med (1997) 4.96
A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med (1995) 4.94
Dual effects of weight and weight gain on breast cancer risk. JAMA (1997) 4.81
Dietary fat and fiber in relation to risk of breast cancer. An 8-year follow-up. JAMA (1992) 4.80
Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range. JAMA (1995) 4.78
Menopause and the risk of coronary heart disease in women. N Engl J Med (1987) 4.70
Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst (1996) 4.66
Weight as a risk factor for clinical diabetes in women. Am J Epidemiol (1990) 4.64
A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women. N Engl J Med (1999) 4.61
A prospective study of passive smoking and coronary heart disease. Circulation (1997) 4.51
A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA (1997) 4.50
Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976. BMJ (1997) 4.49
Birthweight and the risk for type 2 diabetes mellitus in adult women. Ann Intern Med (1999) 4.49
Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care (1997) 4.46
Cigarette smoking, relative weight, and menopause. Am J Epidemiol (1983) 4.46
A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. Am J Clin Nutr (2000) 4.38
Reproducibility and validity of a self-administered physical activity questionnaire for male health professionals. Epidemiology (1996) 4.37
Smoking cessation and decreased risk of stroke in women. JAMA (1993) 4.36
Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA (2001) 4.30
Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA (1996) 4.29
PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet (1997) 4.27
Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr (2001) 4.26
Alcohol consumption and mortality among women. N Engl J Med (1995) 4.22
Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits. BMJ (1996) 4.21
Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med (1997) 4.16
Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ (1999) 4.14
Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med (1995) 4.06
Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet (1998) 3.97
Physical activity and risk of stroke in women. JAMA (2000) 3.95
Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women. Am J Clin Nutr (1999) 3.91
Whole-grain consumption and risk of coronary heart disease: results from the Nurses' Health Study. Am J Clin Nutr (1999) 3.89
Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med (1995) 3.88
Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst (1995) 3.88
Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA (1994) 3.86
A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med (1991) 3.85
Recreational physical activity and the risk of cholecystectomy in women. N Engl J Med (1999) 3.82
Reproducibility and validity of self-reported menopausal status in a prospective cohort study. Am J Epidemiol (1987) 3.77
Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol (1995) 3.76
Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med (1998) 3.73
The validity of recalled weight among younger women. Int J Obes Relat Metab Disord (1995) 3.68
A prospective study of aspirin use and primary prevention of cardiovascular disease in women. JAMA (1991) 3.67
Dietary patterns and the risk of coronary heart disease in women. Arch Intern Med (2001) 3.59
Body weight, weight change, and risk for hypertension in women. Ann Intern Med (1998) 3.56
Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med (1992) 3.54
A prospective study of nutritional factors and hypertension among US men. Circulation (1992) 3.51
A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst (1993) 3.40
Birth weight and adult hypertension, diabetes mellitus, and obesity in US men. Circulation (1996) 3.40
Collection of genomic DNA from adults in epidemiological studies by buccal cytobrush and mouthwash. Cancer Epidemiol Biomarkers Prev (2001) 3.40
Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ (1995) 3.37
Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res (1997) 3.36
Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med (1996) 3.35
A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. men. J Natl Cancer Inst (1994) 3.32
A prospective study of social networks in relation to total mortality and cardiovascular disease in men in the USA. J Epidemiol Community Health (1996) 3.28